Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in

Jae Hyuk Lee1, Hee Tae Yu1, Il Young Oh2

  • 1Division of Cardiology, Department of Internal Medicine, Yonsei University Health System, Seoul, Korea.

Yonsei Medical Journal
|October 27, 2020
PubMed

Insights

Primary prevention implantable cardioverter-defibrillator (ICD) use for ischemic cardiomyopathy is low in Korea. Hospital system factors and patient clinical status significantly impact appropriate ICD implantation rates.

Area of Science:

  • Cardiology
  • Medical Devices
  • Public Health

Background:

  • Implantable cardioverter-defibrillators (ICDs) are standard for primary prevention (PP) in ischemic cardiomyopathy (ICM).
  • PP ICD implantation is notably underutilized in Asian populations.
  • This study addresses the low rates and influencing factors of PP ICD implantation in ICM patients.

Purpose of the Study:

  • To investigate the current rates of PP ICD implantation among eligible ICM patients in Korea.
  • To identify clinical and hospital-related factors associated with appropriate PP ICD implantation.

Main Methods:

  • Prospective, multicenter observational registry (ADVANCE-ICM).
  • Screening and enrollment of ICM patients eligible for PP ICD.
  • Analysis of factors, including hospital systems and patient clinical data, linked to ICD implantation.

Main Results:

  • Only 5.2% of 1453 eligible ICM patients received an ICD.
  • Higher hospital system scores and non-monetary referral incentives were associated with ICD implantation.
  • Multivariate analysis identified hospital system score, high NYHA class (≥III), and younger age (<70) as predictors for ICD implantation.

Conclusions:

  • PP ICD implantation for ICM patients remains underused in Korea.
  • Hospital system factors play a crucial role in improving PP ICD implantation rates.
  • Implementing enhanced screening and referral systems is recommended to increase PP ICD utilization.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
253
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
169
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
224
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
93
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
500
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.5K